Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53


Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer.

Kim MW, Jeong HY, Kang SJ, Jeong IH, Choi MJ, You YM, Im CS, Song IH, Lee TS, Lee JS, Lee A, Park YS.

Theranostics. 2019 Jan 25;9(3):837-852. doi: 10.7150/thno.30228. eCollection 2019.


PET imaging of HER2 expression with an 18F-fluoride labeled aptamer.

Kim HJ, Park JY, Lee TS, Song IH, Cho YL, Chae JR, Kang H, Lim JH, Lee JH, Kang WJ.

PLoS One. 2019 Jan 25;14(1):e0211047. doi: 10.1371/journal.pone.0211047. eCollection 2019.


PET Imaging Biomarkers of Anti-EGFR Immunotherapy in Esophageal Squamous Cell Carcinoma Models.

Lee TS, Song IH, Shin JI, Park YS, Kim JY, Kim KI, Lee YJ, Kang JH.

Cells. 2018 Oct 27;7(11). pii: E187. doi: 10.3390/cells7110187.


Anti-EGFR lipid micellar nanoparticles co-encapsulating quantum dots and paclitaxel for tumor-targeted theranosis.

Kang SJ, Jeong HY, Kim MW, Jeong IH, Choi MJ, You YM, Im CS, Song IH, Lee TS, Park YS.

Nanoscale. 2018 Nov 7;10(41):19338-19350. doi: 10.1039/c8nr05099f. Epub 2018 Oct 11.


Development of 64Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies.

Woo SK, Jang SJ, Seo MJ, Park JH, Kim BS, Kim EJ, Lee YJ, Lee TS, An GI, Song IH, Seo Y, Kim KI, Kang JH.

J Nucl Med. 2019 Jan;60(1):26-33. doi: 10.2967/jnumed.118.210294. Epub 2018 May 18.


Intense Red-Emitting Upconversion Nanophosphors (800 nm-Driven) with a Core/Double-Shell Structure for Dual-Modal Upconversion Luminescence and Magnetic Resonance in Vivo Imaging Applications.

Hong AR, Kim Y, Lee TS, Kim S, Lee K, Kim G, Jang HS.

ACS Appl Mater Interfaces. 2018 Apr 18;10(15):12331-12340. doi: 10.1021/acsami.7b18078. Epub 2018 Apr 4.


Facile metabolic glycan labeling strategy for exosome tracking.

Lee TS, Kim Y, Zhang W, Song IH, Tung CH.

Biochim Biophys Acta Gen Subj. 2018 May;1862(5):1091-1100. doi: 10.1016/j.bbagen.2018.02.001. Epub 2018 Feb 2.


A cell surface clicked navigation system to direct specific bone targeting.

Kim Y, Zhang Z, Shim JH, Lee TS, Tung CH.

Bioorg Med Chem. 2018 Feb 1;26(3):758-764. doi: 10.1016/j.bmc.2017.12.037. Epub 2017 Dec 26.


Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model.

Song IH, Noh Y, Kwon J, Jung JH, Lee BC, Kim KI, Lee YJ, Kang JH, Rhee CS, Lee CH, Lee TS, Choi IJ.

Oncotarget. 2017 Sep 8;8(54):92090-92105. doi: 10.18632/oncotarget.20760. eCollection 2017 Nov 3.


Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles.

Kim MW, Jeong HY, Kang SJ, Choi MJ, You YM, Im CS, Lee TS, Song IH, Lee CG, Rhee KJ, Lee YK, Park YS.

Sci Rep. 2017 Aug 25;7(1):9474. doi: 10.1038/s41598-017-09555-w.


Monitoring of macrophage accumulation in statin-treated atherosclerotic mouse model using sodium iodide symporter imaging system.

Yoo RJ, Kim MH, Woo SK, Kim KI, Lee TS, Choi YK, Kang JH, Lim SM, Lee YJ.

Nucl Med Biol. 2017 May;48:45-51. doi: 10.1016/j.nucmedbio.2017.01.009. Epub 2017 Jan 25.


Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma.

Cho S, Lee TS, Song IH, Kim AR, Lee YJ, Kim H, Hwang H, Jeong MS, Kang SG, Hong HJ.

PLoS One. 2017 Feb 6;12(2):e0170078. doi: 10.1371/journal.pone.0170078. eCollection 2017.


A Bioluminogenic Probe for Monitoring Tyrosinase Activity.

Wang J, Lee TS, Zhang Z, Tung CH.

Chem Asian J. 2017 Feb 16;12(4):397-400. doi: 10.1002/asia.201601659. Epub 2017 Jan 19.


Hybridization-based aptamer labeling using complementary oligonucleotide platform for PET and optical imaging.

Park JY, Lee TS, Song IH, Cho YL, Chae JR, Yun M, Kang H, Lee JH, Lim JH, Cho WG, Kang WJ.

Biomaterials. 2016 Sep;100:143-51. doi: 10.1016/j.biomaterials.2016.05.035. Epub 2016 May 24.


In vivo monitoring of CD44+ cancer stem-like cells by γ-irradiation in breast cancer.

Kim MH, Kim MH, Kim KS, Park MJ, Jeong JH, Park SW, Ji YH, Kim KI, Lee TS, Ryu PY, Kang JH, Lee YJ.

Int J Oncol. 2016 Jun;48(6):2277-86. doi: 10.3892/ijo.2016.3493. Epub 2016 Apr 18.


Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.

Song IH, Lee TS, Park YS, Lee JS, Lee BC, Moon BS, An GI, Lee HW, Kim KI, Lee YJ, Kang JH, Lim SM.

J Nucl Med. 2016 Jul;57(7):1105-11. doi: 10.2967/jnumed.115.167155. Epub 2016 Feb 25.


Detection of metastatic tumors after γ-irradiation using longitudinal molecular imaging and gene expression profiling of metastatic tumor nodules.

Jang SJ, Kang JH, Lee YJ, Kim KI, Lee TS, Choe JG, Lim SM.

Int J Oncol. 2016 Apr;48(4):1361-8. doi: 10.3892/ijo.2016.3384. Epub 2016 Feb 8.


Evaluation of safety and efficacy of adipose-derived stem cells in rat myocardial infarction model using hexadecyl-4-[¹²⁴I]iodobenzoate for cell tracking.

Kim MH, Lee KC, An GI, Woo SK, Park NW, Kim BI, Eom KD, Kim KI, Lee TS, Kim CW, Yoo J, Kang JH, Lee YJ.

Appl Radiat Isot. 2016 Feb;108:116-123. doi: 10.1016/j.apradiso.2015.12.039. Epub 2015 Dec 17.


Generation of a human antibody that inhibits TSPAN8-mediated invasion of metastatic colorectal cancer cells.

Kim TK, Park CS, Jeoung MH, Lee WR, Go NK, Choi JR, Lee TS, Shim H, Lee S.

Biochem Biophys Res Commun. 2015 Dec 25;468(4):774-80. doi: 10.1016/j.bbrc.2015.11.031. Epub 2015 Nov 10.


Simple Methods for Tracking Stem Cells with (64)Cu-Labeled DOTA-hexadecyl-benzoate.

Kim MH, Woo SK, Kim KI, Lee TS, Kim CW, Kang JH, Kim BI, Lim SM, Lee KC, Lee YJ.

ACS Med Chem Lett. 2015 Apr 7;6(5):528-30. doi: 10.1021/acsmedchemlett.5b00021. eCollection 2015 May 14.

Supplemental Content

Loading ...
Support Center